Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Sigrid Therapeutics AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -20,558 More Arrow -14,622 Less Arrow -15,080
EBITDA -20,776 More Arrow -14,380 Less Arrow -14,772
Total assets 49,322 Less Arrow 36,761 More Arrow 47,173
Current assets 44,848 Less Arrow 34,594 More Arrow 45,350
Current liabilities 6,504 Less Arrow 3,066 Less Arrow 2,653
Equity capital 42,818 Less Arrow 33,695 More Arrow 44,520
- share capital 488 Less Arrow 438 More Arrow 468
Employees (average) 7 More Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 86.8% More Arrow 91.7% More Arrow 94.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -41.7% More Arrow -39.8% More Arrow -32.0%
Current ratio 689.5% More Arrow 1128.3% More Arrow 1709.4%
Return on equity (ROE) -48.0% More Arrow -43.4% More Arrow -33.9%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -2 More Arrow 2 Equal arrow 2
Chg. No. of employees % -22% More Arrow 29% More Arrow 40%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.